HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orly Lipsitz Selected Research

Insulin Resistance

1/2023Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder.
1/2021Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder.
1/2020Effect of body anthropometrics on brain structure of offspring of parents with bipolar disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Orly Lipsitz Research Topics

Disease

26Treatment-Resistant Depressive Disorder
01/2022 - 01/2020
15Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 01/2020
11Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 01/2020
10Mood Disorders (Mood Disorder)
11/2022 - 11/2020
3Inflammation (Inflammations)
01/2023 - 01/2020
3Insulin Resistance
01/2023 - 01/2020
2Anhedonia
01/2022 - 11/2020
2Mental Disorders (Mental Disorder)
01/2021 - 12/2020
1Postpartum Depression (Post-Natal Depression)
11/2022
1Neurobehavioral Manifestations
10/2022
1Psychomotor Agitation (Akathisia)
01/2022
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022
1Tardive Dyskinesia
12/2021
1Hematuria
04/2021
1Dysuria
04/2021
1Nausea
01/2021
1Headache (Headaches)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021
1Alcoholism (Alcohol Abuse)
01/2021
1COVID-19
01/2021
1Weight Gain
11/2020
1Weight Loss (Weight Reduction)
11/2020
1Psychotic Disorders (Schizoaffective Disorder)
08/2020
1Mania (Manias)
08/2020

Drug/Important Bio-Agent (IBA)

33KetamineFDA LinkGeneric
11/2022 - 01/2020
17Antidepressive Agents (Antidepressants)IBA
01/2023 - 01/2020
5EsketamineIBA
01/2022 - 01/2021
3Psilocybin (Psilocibin)IBA
01/2022 - 12/2020
2Therapeutic UsesIBA
01/2022 - 01/2021
2Hallucinogens (Psychedelics)IBA
01/2021 - 12/2020
2N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
01/2021 - 12/2020
1Tuberculin (PPD)IBA
11/2022
1Antipsychotic Agents (Antipsychotics)IBA
12/2021
1Nerve Growth Factors (Neurotrophins)IBA
10/2021
1Pentoxifylline (Trental)FDA LinkGeneric
10/2021
1Immunoglobulin E (IgE)IBA
04/2021
1Anesthetics (Anesthetic Agents)IBA
04/2021
1Ibogaine (Endabuse)IBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1VortioxetineIBA
01/2021
1Lysergic Acid Diethylamide (LSD)IBA
01/2021
1Bupropion (Wellbutrin)FDA LinkGeneric
11/2020
1Histamine (Histamine Dihydrochloride)FDA Link
11/2020
1Serotonin (5 Hydroxytryptamine)IBA
11/2020
1Mirtazapine (Rexer)FDA LinkGeneric
11/2020
1AdiponectinIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1CytokinesIBA
01/2020
1Adenosine Diphosphate (ADP)IBA
01/2020
1C-Reactive ProteinIBA
01/2020
1Hormones (Hormone)IBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2021